Cyclooxygenase-2 in Lung Carcinogenesis and Chemoprevention

This publication has 51 references indexed in Scilit:

• COX‐2‐dependent stabilization of survivin in non‐small cell lung cancer
  The FASEB Journal, 2003
• Celecoxib, a Selective Cyclo-Oxygenase-2 Inhibitor, Enhances the Response to Preoperative Paclitaxel and Carboplatin in Early-Stage Non–Small-Cell Lung Cancer
  Journal of Clinical Oncology, 2003
• Cancer Statistics, 2003
  CA: A Cancer Journal for Clinicians, 2003
• Clinical impact of novel treatment strategies
  Oncogene, 2002
• Cyclooxygenase-2 Inducing Mcl-1-dependent Survival Mechanism in Human Lung Adenocarcinoma CL1.0 Cells
  Journal of Biological Chemistry, 2001
• Global cancer statistics in the year 2000
  The Lancet Oncology, 2001
• The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease
  European Journal Of Cancer, 2000
• Inhibition of lung tumourigenesis by sulindac: comparison of two experimental protocols
  Carcinogenesis: Integrative Cancer Research, 1997
• Nonsteroidal anti-inflammatory drug use and sporadic colorectal adenomas
  Gastroenterology, 1995
• Tumor Angiogenesis: Therapeutic Implications
  New England Journal of Medicine, 1971